Story perspectives

Trump's Weight Loss Drug Initiative Interrupted by Collapse

11/7/2025

50 8

Summary

Story summary

President Donald Trump announced a new initiative to subsidize weight loss drugs during a press conference in the Oval Office.
The event was interrupted when Novo Nordisk executive Gordon Findlay collapsed, prompting immediate medical assistance.
Health Secretary Robert Kennedy Jr. left the scene, while White House Press Secretary Karoline Leavitt later confirmed Findlay was "okay" and that the conference would resume.
The initiative aims to reduce the costs of effective obesity medications, contributing to a recent decline in U.S. obesity rates.

1 of 1

Story summary

President Donald Trump announced a new initiative to subsidize weight loss drugs during a press conference in the Oval Office.
The event was interrupted when Novo Nordisk executive Gordon Findlay collapsed, prompting immediate medical assistance.
Health Secretary Robert Kennedy Jr. left the scene, while White House Press Secretary Karoline Leavitt later confirmed Findlay was "okay" and that the conference would resume.
The initiative aims to reduce the costs of effective obesity medications, contributing to a recent decline in U.S. obesity rates.